SCHEDULE: Core Scientific Stakeholder Filing
Beneficial Ownership Filing
Multiple entities within the Susquehanna Investment Group have collectively reported beneficial ownership of 4.6% of Core Scientific, Inc. common stock as of March 31, 2025.
Summary
- This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership reporting for Core Scientific, Inc.
- The reporting persons are G1 Execution Services, LLC, SIG Brokerage, LP, Susquehanna Investment Group, and Susquehanna Securities, LLC.
- Collectively, these entities beneficially own 14,631,891 shares of Core Scientific, Inc. common stock.
- This represents 4.6% of the total class of securities outstanding.
- The filing states that these entities are affiliated independent broker-dealers and may be deemed a group.
- Each reporting person disclaims beneficial ownership of shares owned directly by another reporting person within the group.
- The total number of outstanding shares as of March 23, 2026, was 315,594,802.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on existing beneficial ownership rather than announcing new strategic initiatives or financial performance.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors or other entities that acquire a significant stake in a company, but do not intend to control or influence the company's management. A 4.6% stake is a notable position for a broker-dealer group.
Stakeholder Impact
- Shareholders: The filing provides transparency regarding significant beneficial ownership, which can inform investor sentiment and understanding of the shareholder base.
- Company Management: The filing indicates a substantial passive stake held by a group of broker-dealers, which may be relevant for strategic planning and investor relations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of Event Which Requires Filing of this Statement |
| 03/23/2026 | Date as of which outstanding shares were reported |
| 03/31/2026 | Date of filing of Company's Proxy Statement on Schedule 14A |
| 05/13/2026 | Date of certification and signature for the filing |
Keywords
Core Scientific, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Broker-dealer, Investment Group
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.